Biotech IPOs Are Rocking
The good times in the Biotech IPO market continue. Good piece on some of the latest developments.
With biopharma IPOs surging, GoodRx guns for $750M raise
The 2020 biopharma IPO wave has picked up a company or two that doesn't look like your traditional drug developer. In June, most notably, Royalty Pharma, a company that has made a tidy business over the years buying up future royalties for approved and experimental drugs, nabbed the largest biotech